Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Oberdhan

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Neuropsychiatric Disease and Treatment|October 16, 2023
Understanding Patients' Experiences with Borderline Personality Disorder: Qualitative InterviewsDana DiBenedetti, Katherine Kosa, Heidi C Waters, et al.
Kidney Medicine|January 23, 2023
Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative StudyDorothee Oberdhan, Andrew C Palsgrove, Jason C Cole, et al.
Neuropsychiatric Disease and Treatment|March 29, 2022
Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset SeizuresDorothee Oberdhan, Elizabeth Bacci, Jennifer N Hill, et al.
Neuropsychiatric Disease and Treatment|July 17, 2020
Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity DisorderJessica T Markowitz, Dorothee Oberdhan, Anna Ciesluk, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataTyler Knight, Caroline Schaefer, Holly Krasa, et al.
Journal of Medical Economics|January 19, 2021
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stagePatrick Gagnon-Sanschagrin, Yawen Liang, Myrlene Sanon, et al.
BMC Health Services Research|February 20, 2020
The societal economic burden of autosomal dominant polycystic kidney disease in the United StatesMartin Cloutier, Ameur M Manceur, Annie Guerin, et al.
Kidney Medicine|April 7, 2022
Polycystic Kidney Disease-Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative StudyDorothee Oberdhan, Franz Schaefer, Jason C Cole, et al.
Frontiers in Neurology|August 7, 2024
Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementiaJuliette Meunier, Kristin Creel, Angély Loubert, et al.
Advances in Therapy|March 10, 2026
The PKD Daily: Development and Content Validation of a Hybrid Diary for Tracking Urinary Events in Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD)Meaghan O'Connor, Lynne Broderick, Laura Tesler Waldman, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Neuropsychiatric Disease and Treatment|October 16, 2023
Understanding Patients' Experiences with Borderline Personality Disorder: Qualitative InterviewsDana DiBenedetti, Katherine Kosa, Heidi C Waters, et al.
Kidney Medicine|January 23, 2023
Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative StudyDorothee Oberdhan, Andrew C Palsgrove, Jason C Cole, et al.
Neuropsychiatric Disease and Treatment|March 29, 2022
Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset SeizuresDorothee Oberdhan, Elizabeth Bacci, Jennifer N Hill, et al.
Neuropsychiatric Disease and Treatment|July 17, 2020
Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity DisorderJessica T Markowitz, Dorothee Oberdhan, Anna Ciesluk, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataTyler Knight, Caroline Schaefer, Holly Krasa, et al.
Journal of Medical Economics|January 19, 2021
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stagePatrick Gagnon-Sanschagrin, Yawen Liang, Myrlene Sanon, et al.
BMC Health Services Research|February 20, 2020
The societal economic burden of autosomal dominant polycystic kidney disease in the United StatesMartin Cloutier, Ameur M Manceur, Annie Guerin, et al.
Kidney Medicine|April 7, 2022
Polycystic Kidney Disease-Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative StudyDorothee Oberdhan, Franz Schaefer, Jason C Cole, et al.
Frontiers in Neurology|August 7, 2024
Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementiaJuliette Meunier, Kristin Creel, Angély Loubert, et al.
Advances in Therapy|March 10, 2026
The PKD Daily: Development and Content Validation of a Hybrid Diary for Tracking Urinary Events in Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD)Meaghan O'Connor, Lynne Broderick, Laura Tesler Waldman, et al.
Pageof 4